Key result
B2TT-3A3D and B2TT-3D3A dendrimers elicited high neutralizing antibody titers against type O FMDVs, with B2TT-3A3D inducing higher IgG titers and a better response to boosting.
Why the study?
To assess whether the inclusion and orientation of T-3A and T-3D T-cell epitopes in a single dendrimeric peptide molecule could modulate immunogenicity in pigs.
The inclusion and orientation of T-cell epitopes in B2T-type dendrimers influence the T-cell response and neutralizing antibody production, highlighting their potential as next-generation FMD vaccines.
May advance dendrimer platforms for type O FMDV; leaves open translation to protective efficacy in livestock.
Dendrimeric peptide constructs based on a lysine core that comprises both B- and T-cell epitopes of foot-and-mouth disease virus (FMDV) have proven a successful strategy for the development of FMD vaccines. Specifically, B2T dendrimers displaying two copies of the major type O FMDV antigenic B-cell epitope located on the virus capsid [VP1 (140–158)], covalently linked to a heterotypic T-cell epitope from either non-structural protein 3A [3A (21–35)] or 3D [3D (56–70)], named B2T-3A and B2T-3D, respectively, elicit high levels of neutralizing antibodies (nAbs) and IFN-γ-producing cells in pigs. To assess whether the inclusion and orientation of T-3A and T-3D T-cell epitopes in a single molecule could modulate immunogenicity, dendrimers with T epitopes juxtaposed in both possible orientations, i.e., constructs B2TT-3A3D and B2TT-3D3A, were made and tested in pigs. Both dendrimers elicited high nAbs titers that broadly neutralized type O FMDVs, although B2TT-3D3A did not respond to boosting, and induced lower IgGs titers, in particular IgG2, than B2TT-3A3D. Pigs immunized with B2,a control dendrimer displaying two B-cell epitope copies and no T-cell epitope, gave no nABs, confirming T-3A and T-3D as T helper epitopes. The T-3D peptide was found to be an immunodominant, as it produced more IFN-γ expressing cells than T-3A in thein vitrorecall assay. Besides, in pigs immunized with the different dendrimeric peptides, CD4+T-cells were the major subset contributing to IFN-γ expression uponin vitrorecall, and depletion of CD4+cells from PBMCs abolished the production of this cytokine. Most CD4+IFN-γ+cells showed a memory (CD4+2E3−) and a multifunctional phenotype, as they expressed both IFN-γ and TNF-α, suggesting that the peptides induced a potent Th1 pro-inflammatory response. Furthermore, not only the presence, but also the orientation of T-cell epitopes influenced the T-cell response, as B2TT-3D3A and B2groups had fewer cells expressing both cytokines. These results help understand how B2T-type dendrimers triggers T-cell populations, highlighting their potential as next-generation FMD vaccines.
No takes yet. Share an insight, caveat, or question.
León et al. (2021) studied Foot-and-mouth disease (FMD) vaccination (n=20). B2T dendrimers (B2TT-3A3D and B2TT-3D3A) vs. B2 dendrimer and PBS was evaluated on Neutralizing antibody titers and IFN-g expressing cells. B2TT-3A3D and B2TT-3D3A dendrimers elicited high neutralizing antibody titers against type O FMDVs, with B2TT-3A3D inducing higher IgG titers and a better response to boosting.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: